Scholar Rock Holding Corp
SRRK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001727196
No open-market purchases or sales by Scholar Rock Holding Corp insiders were filed in the last 90 days; 306 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Scholar Rock Holding Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 124 | 105 | −19 |
| Shares | 27.9M | 28.6M | +694.4K (+2.5%) |
| Value | $1.41B | $825.5M | −$584.1M (−41.4%) |
New holders (9)
Institutions that held Scholar Rock Holding Corp at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Trust Advisors LP | 34,829 | $1.01M | 0.00% |
| Two Sigma Investments, LP | 34,334 | $992.0K | 0.00% |
| Dimensional Fund Advisors LP | 30,850 | $892.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 27,914 | $807.0K | 0.01% |
| AlphaCrest Capital Management LLC | 27,079 | $783.0K | 0.03% |
| Schonfeld Strategic Advisors LLC | 10,600 | $306.0K | 0.00% |
| Jane Street Group, LLC | 8,335 | $241.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,150 | $33.0K | 0.00% |
| UBS Group AG | 708 | $20.0K | 0.00% |
Sold out (28)
Institutions that held Scholar Rock Holding Corp at the end of Q1 2021 and filed for Q2 2021 without it.